×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中南大学 [2]
西安交通大学 [1]
湖南中医药大学 [1]
内容类型
期刊论文 [4]
发表日期
2017 [1]
2016 [3]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共4条,第1-4条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
期刊论文
Cancer Treatment Reviews, 2017, 卷号: 54, 页码: 24-33
作者:
Peng, Mei*
;
Darko, Kwame Oteng
;
Tao, Ting
;
Huang, Yanjun
;
Su, Qiongli
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/03
AIs
aromatase inhibitors
AMPK
Adenosine Monophosphate-Activated Protein Kinase
AR
androgen
ATM
Ataxia Telangiectasia Mutated
ATP
Adenosine Triphosphate
BCSS
breast cancer specific survival
CK-MB
Creatine Kinase-MB
CREB1
cAMP Response Element-Binding Protein 1
CSC
cancer stem cell
DFS
disease-free survival
DHFU
dihydrofluorouracil
DPD
dihydropyrimidine dehydrogenase
EpCAM
Epithelial Cell Adhesion Molecule
ER
estrogen
ERCC1
excision repair cross-complementary 1
ERK
extracellular signal-regulated kinases
EZH2
enhancer of zeste homolog 2
FdUMP
fluorodeoxyuridine monophosphate
FdUTP
fluorodeoxyuridine triphosphate
FHC
ferritin heavy chain
FUTP
fluorouridine triphosphate
HbA1C
hemoglobin A1c
HER
Human Epidermal Growth Factor Receptor
HIF-1α
hypoxia-inducible factor-1α
HK
hexokinase
IGF1R
insulin growth factor 1 receptor
LDH
lactate dehydrogenase
MDA
Muscular Dystrophy Association
MMP
Matrix Metallopeptidase
MRP1
multidrug resistance-associated protein 1
mTOR
mammalian target of rapamycin
MTX
methotrexate
NCCN
National Comprehensive Cancer Network
OS
overall survival
pCR
Pathologic Complete Response
PDGFR
platelet-derived growth factor receptors
PFS
progression-free survival
PKA
protein kinase A
PR
progesterone receptor
RFS
relapse-free survival
SOD
superoxide dismutase
TAM
tamoxifen
TCA
tricarboxlic acid
TS
thymidylate synthase
Combination
Mechanisms
Metformin
Chemotherapeutic drugs
High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.
期刊论文
Oncotarget, 2016, 卷号: 7, 期号: 8, 页码: 9102-9117
作者:
Peng, Mei
;
Su, Qiongli
;
Zeng, Qing
;
Li, Le
;
Liu, Zhihong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
AMPK
bladder cancer
localized administration
metformin
preclinical model
High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model
期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: [db:dc_citation_issue], 页码: 9102-9117
作者:
Peng, Mei
;
Su, Qiongli
;
Zeng, Qing
;
Li, Le
;
Liu, Zhihong
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/02
bladder cancer
AMPK
preclinical model
metformin
localized administration
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
期刊论文
SCIENTIFIC REPORTS, 2016, 卷号: 6, 页码: 28611
作者:
Peng, Mei
;
Huang, Yanjun
;
Tao, Ting
;
Peng, Cai-Yun
;
Su, Qiongli
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/27
©版权所有 ©2017 CSpace - Powered by
CSpace